Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Marijuana Moment reports. DeaOutoftheway @RTTpsilocybin pic.twitter.com/1NJWt2cJWn. aeidinger) May 9, 2022.

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

MAY 31, 2022

The short answer is: that current legal options (i.e. legal at the state level or the state and federal level) are limited. Mr. Pollan notes that he would not have qualified for any of the active clinical trials, so beyond sticking to Ketamine, his only option was unregulated therapy with underground therapists. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

FEBRUARY 28, 2022

This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. Moreover, because Indigenous communities pioneered many aspects of modern psychedelic therapies, their patenting by Western corporations may promote biopiracy, the exploitation of Indigenous knowledge without compensation.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. More recently, MDMA therapy has inched closer to FDA approval. DEA and the Controlled Substances Act.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). territories. This means that U.S. Is the future exciting? .”

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

NewsMunchies

NOVEMBER 12, 2021

As the cannabis industry continues to grow and evolve with legalization achieved in many parts of the world, we’re seeing an increase in activity related to another substance that will hopefully be removed from the list of controlled substances – psilocybin. As such, magic mushroom therapy offers hope. Let’s put science first.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . Promising clinical trial results have generated much interest in studying MDMA as a catalyst to therapy for PTSD and related conditions — and an increased demand for pharmaceutical-grade MDMA.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JULY 9, 2021

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.”

Law 105

Law Therapy Clinical Trials Research and Development 105

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Is Medical Cannabis Legal? tetrahydrocannabinol (THC) are legal.

Law 62

Law Chronic Pain Conditions Legislation 62

SpeedWeed

MAY 15, 2021

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. The subjects were randomly divided into two groups, each of which received three individual sessions of talk therapy. Image via. View original article.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Veriheal

DECEMBER 27, 2022

Scientists Hope New Findings Will Help Expand Research on Psychedelic Therapy. In light of this, the Drug Enforcement Administration (DEA) has announced its intention to substantially increase the production quota of psychedelics such as LSD, psilocybin, and mescaline due to be studied in 2023. .

Research and Development 95

Research and Development Therapy Consumption DEA 95

MedicalJane

JUNE 29, 2018

. “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies.” The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. ” –FDA Commissioner Scott Gottlieb.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Which Political Party Will Legalize Weed? Mainstreaming Cannabinoids – Path To Legalization.

Research and Development 52

Research and Development Events Topical Policy 52

SpeedWeed

AUGUST 16, 2021

And we’re gonna have to change therapies to try to win this battle. Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. I have cancer of the bone now. And it’s pretty rampant from my chest to my toes.

DEA 52

DEA Patients Therapy Cannabis 52

Veriheal

JUNE 29, 2021

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. The FDA refers to this program as the expanded access program on their website. Introducing the Right to Try Act. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Still, for all its promise, would-be clinic owners, practitioners, and consumers may be confused about the legality of such clinics.

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Canna Law Blog

NOVEMBER 6, 2021

But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Still, for all its promise, would-be clinic owners, practitioners, and consumers may be confused about the legality of such clinics.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

APRIL 13, 2022

North American Industry Leader in Psychedelic Therapy and Research. Shared mission of responsibly reintroducing psychedelic therapy to mental healthcare. “Since Numinus began, we have always strived to be the most trusted, evidence-based leader in psychedelic-assisted therapy and medicine. NEWS PROVIDED BY. ” Mr. .

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

MAY 15, 2023

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. 1 Related Stories What’s the deal with ketamine? 1 Related Stories What’s the deal with ketamine?

Therapy 78

Therapy Access Blood Pressure Treatment 78

Sensi Seeds

NOVEMBER 28, 2018

Is CBD Legal in Spain? Food and Drug Administration (FDA) earlier this year, and convince the DEA to reclassify CBD from a Schedule I (most restrictive category) to a Schedule V drug (least restrictive category.) As a result, GW’s latest CBD product, EPIDIOLEX ® was entered into the Spanish pharmacopeia over the summer.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.

DEA 99

DEA Chronic Pain Treatment Therapy 99

The Cannigma

FEBRUARY 16, 2022

So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. It’s Dr. Codi Peterson here with our regularly scheduled segment with Americans for Safe Access.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

APRIL 4, 2022

Congress, signed into law by President Trump, with 41 state enactments, give terminally ill patients access to experimental medicines still in development? But the Drug Enforcement Agency is barring access to one such experimental medicine: psilocybin, also known in its fungal form as “magic mushrooms.”. Read more at.

Access 52

Access Patients DEA Research and Development 52

SpeedWeed

JULY 22, 2021

Despite all the work that has been happening at the state level to legalize medical and recreational cannabis, it is still classified federally as a Schedule I drug in the U.S., The attorney general can also choose to waive that right and let the DEA review the petition instead. . as most cannabis enthusiasts well know.

DEA 52

DEA Therapy Cannabis Patients 52

Cannabis Law Report

JULY 30, 2019

Considering our current armed service use restrictions and the lack of legal tax and employment considerations for marijuana use, like the nation, Florida is not quite “ there ” yet. . Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S.

Marijuana 45

Marijuana Patients Research and Development Programs 45